Lim, S., Baker, M., Derebail, V., Chaichian, Y., Genovese, M., Rao, P., . . . Tumlin, J. (2020). Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.
MLA (8th ed.) CitationLim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.
Warning: These citations may not always be 100% accurate.